Lymphoma
Read the topic background here, then explore the labeled visual and structured learning explanations on this page.
Read explanation on this page ↓ See diagram ↓Lymphoma — on-site reading
An introductory overview for this topic. The article introduction is reproduced here, so you do not need to leave MedAtlas to read it. It may not match the latest official medical guidance.
Lymphoma is a group of blood and lymph tumors that develop from lymphocytes (a type of white blood cell). The name typically refers to just the cancerous versions rather than all such tumors. Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The enlarged lymph nodes are usually painless. The sweats are most common at night.
The two main categories of lymphomas are the non-Hodgkin lymphoma (NHL) (90% of cases) and Hodgkin lymphoma (HL) (10%). Lymphomas, leukemias and myelomas are a part of the broader group of tumors of the hematopoietic and lymphoid tissues.
Risk factors for Hodgkin lymphoma include infection with Epstein–Barr virus and a history of the disease in the family. Risk factors for common types of non-Hodgkin lymphomas include autoimmune diseases, HIV/AIDS, infection with human T-lymphotropic virus, immunosuppressant medications, and some pesticides. Eating large amounts of red meat and tobacco smoking may also increase the risk. Diagnosis, if enlarged lymph nodes are present, is usually by lymph node biopsy. Blood, urine, and bone marrow testing may also be useful in the diagnosis. Medical imaging may then be done to determine if and where the cancer has spread. Lymphoma most often spreads to the lungs, liver, and brain.
Treatment may involve one or more of the following: chemotherapy, radiation therapy, proton therapy, targeted therapy, and surgery. In some non-Hodgkin lymphomas, an increased amount of protein produced by the lymphoma cells causes the blood to become so thick that plasmapheresis is performed to remove the protein. Watchful waiting may be appropriate for certain types. The outcome depends on the subtype, with some being curable and treatment prolonging survival in most. The five-year survival rate in the United States for all Hodgkin lymphoma subtypes is 89%, while that for non-Hodgkin lymphomas is 74%. Worldwide, lymphomas developed in 566,000 people in 2012 and caused 305,000 deaths. They make up 3–4% of all cancers, making them as a group the seventh-most-common form. In children, they are the third-most-common cancer. They occur more often in the developed world than in the developing world.
How this connects to Clinical Haematology
Blood and marrow disorders involve cell production and survival, immune function or the regulation of clotting and bleeding. A blood count or isolated biomarker is not a diagnosis: peripheral smear findings, cell lineage, clinical history and relevant marrow or molecular tests may be necessary.
Text credit: Wikipedia contributors, “Lymphoma”, original article · authors & revision history · CC BY-SA 4.0. Unmodified opening extract, accessed 24 September 2026. This Wikipedia-derived section is provided under CC BY-SA 4.0; the independent MedAtlas notes and design are separate works.
Lymphoma · visual study map
Scalable vector illustration. Labeled conceptual map, not a precise anatomical, histological or diagnostic image.The wording in this learning map is adapted from the attributed Wikipedia background section below (CC BY-SA 4.0).
What the underlying subject studies
At postgraduate and higher-specialty level, begin with normal anatomy and physiology of the relevant organ system, then compare distinct disease mechanisms, their evidence base and the limitations of available investigations.
How mechanisms and evidence connect
Advanced study requires evidence appraisal, multidisciplinary interpretation and a clear distinction between established facts, hypotheses and research findings. Procedural, diagnostic and prescribing skills must be learned under an accredited program.
How to develop a sound explanation
Identify the scope of this topic within the named specialty, connect it to the applicable patient population and formulate a structured question that can be answered using current specialty literature and supervised teaching.
References and verification (optional)
All reading material on this page appears above. The links below are for checking the primary syllabus, research or source attribution, not requirements for opening this lesson.